GSK Appeals Against NICE Decision To Deny Women Advanced Breast Cancer Treatment, Tyv

[News]

GlaxoSmithKline (GSK) confirmed that it is to appeal against the decision by NICE to deny NHS funding for Tyverb® (lapatinib), a treatment for an aggressive form of advanced breast cancer (ErbB2-positive).1 If successful the appeal will enable the NHS to offer a similar level of access to lapatinib as other EU countries.

More... (http://www.medicalnewstoday.com/articles/144331.php)

[chrisy]

This is good news, I guess, but it is quite disturbing to read acknowledgements that yes, this is effective but it's not worth the money. I think I'm worth it.

[Ellie F]

Glad we did the petition and got support from our sisters on the board. I think i'm worth it to! Shame on the British government who recklessly spend taxpayers money on wars and bankers but deny it's citizens life prolonging medication.